Comparison of Survival Times for Dogs with Pituitary‐Dependent Hyperadrenocorticism in a Primary‐Care Hospital: Treated with Trilostane versus Untreated
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Veterinary Internal Medicine"
DOI: 10.1111/jvim.14617
Abstract: Background Although pituitary‐dependent hyperadrenocorticism (PDH) is one of the most common endocrinopathies in dogs, the effects of withholding treatment on survival time in dogs with PDH remain unclear. Hypothesis/Objectives The purpose of this study was… read more here.
Keywords: dogs pdh; times dogs; pituitary dependent; treated trilostane ... See more keywords
Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
Sign Up to like & getrecommendations! Published in 2020 at "Vaccines"
DOI: 10.3390/vaccines8030547
Abstract: It is unknown how dogs with hyperadrenocorticism (HAC) respond to vaccination. This study measured antibodies against canine parvovirus (CPV) in dogs with HAC treated with trilostane before and after CPV vaccination, and compared the immune… read more here.
Keywords: response; treated trilostane; vaccination; healthy dogs ... See more keywords